Today's Trading
Day Low 5.700
Day High 6.100
Open:5.850
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Recently Viewed
More stories below advertisement
FEATURE-EMPTY
Description
Lexaria Bioscience Corp is a food science company. The company's food sciences activities include the development of the proprietary nutrient infusion technologies for the production of superfoods, and the production of enhanced food products under two consumer product brands, ViPova and Lexaria Energy. The company's patented lipid nutrient infusion technology DehydraTECHTM is believed to improve taste, rapidity, and delivery of bioactive compounds that include cannabinoids, vitamins NSAIDs Nicotine, and other molecules. Its operating segment includes Intellectual Property Licensing and Consumer Products. The company generates maximum revenue from Intellectual Property Licensing segment.Fundamentals
Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book
Earnings
Corporate earnings are provided from Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.
Analyst Research
Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.
No rating
Latest Press Releases
Lexaria Appoints New Board Member
- ACCESSWIRE - Fri Jan 15, 2:35PM CST
ACCESSWIRE - CMTX
Fri Jan 15, 2:35PM CST
KELOWNA, BC / ACCESSWIRE / January 15, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors.
Lexaria Bioscience Corp. Announces Closing of $11 Million Public Offering with Full Exercise of Underwriter Option to Purchase Additional Shares and Warrants
- ACCESSWIRE - Fri Jan 15, 5:30AM CST
ACCESSWIRE - CMTX
Fri Jan 15, 5:30AM CST
KELOWNA, BC / ACCESSWIRE / January 15, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company") today announced the closing of its previously announced underwritten public offering (the "Offering") of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada.
Lexaria Bioscience Corp. Announces Closing of $11 Million Public Offering with Full Exercise of Underwriter Option to Purchase Additional Shares and Warrants
- TheNewswire.ca - Fri Jan 15, 5:30AM CST
TheNewswire.ca - CMTX
Fri Jan 15, 5:30AM CST
(via TheNewswire)
Price History Describes more index sector components
Price Performance
| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 5.100 +15.88% increase on 01/12/21 | Period Open:9.450 | 11.700 -49.49% decrease on 12/23/20 | -3.540 (-37.46%) decrease since 12/18/20 |
| 3-Month | 5.100 +15.88% increase on 01/12/21 | Period Open:7.500 | 13.200 -55.23% decrease on 12/14/20 | -1.590 (-21.20%) decrease since 10/16/20 |
| 52-Week | 5.100 +15.88% increase on 01/12/21 | Period Open:19.500 | 22.500 -73.73% decrease on 01/23/20 | -13.590 (-69.69%) decrease since 01/17/20 |
More stories below advertisement